Science and Research

FDA Approves New Administration Method for Keytruda (pembrolizumab)

2025-09-22T11:46:06-05:00September 22nd, 2025|Hot Topics, News, Science and Research|

On September 19, 2025, the U.S. Food and Drug Administration (FDA) approved a new administration method for Keytruda (pembrolizumab). Under the new approval, Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) can now be given by subcutaneous injection, commonly known as a shot, [...]

GO2 for Lung Cancer and ALCMI Launch SUCCEED, a Groundbreaking Remote Clinical Study Targeting Small Cell Lung Cancer

2025-09-22T14:45:24-05:00June 12th, 2025|Hot Topics, News, Science and Research, Small Cell Lung Cancer, Small Cell Lung Cancer Spotlight|

Innovative decentralized trial aims to increase patient participation and accelerate research for one of the deadliest, under-researched lung cancers  SAN CARLOS, CA – June 12, 2025 — GO2 for Lung Cancer (GO2) and the Addario Lung Cancer Medical Institute [...]

Go to Top